Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells
暂无分享,去创建一个
C. Janeway | F. Wong | R. Flavell | D. Picarella | I. Grewal | K. D. Grewal | C. A. Janeway | I S Grewal | F. S. Wong | D E Picarella | R. A. Flavell
[1] R. Tisch,et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.
[2] A. Signore,et al. NOD mouse colonies around the world--recent facts and figures. , 1993, Immunology today.
[3] J. Todd,et al. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. , 1993, Science.
[4] L. Orci,et al. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes , 1992, The Journal of experimental medicine.
[5] M. Mcdaniel,et al. Does Nitric Oxide Mediate Autoimmune Destruction of β-Cells?: Possible Therapeutic Interventions in IDDM , 1992, Diabetes.
[6] H. Mcdevitt,et al. Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. , 1992, International immunology.
[7] C. Janeway,et al. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Kikutani,et al. The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.
[9] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.
[10] N. Welsh,et al. Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells. , 1991, Autoimmunity.
[11] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.
[12] H. Mcdevitt,et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Pociot,et al. Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. , 1990, Current topics in microbiology and immunology.
[14] G. Eisenbarth,et al. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.
[15] G. Nepom. HLA and type I diabetes. , 1990, Immunology today.
[16] J. Satoh,et al. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. , 1989, The Journal of clinical investigation.
[17] E. Bonifacio,et al. PREDICTING INSULIN-DEPENDENT DIABETES , 1988, The Lancet.
[18] L. Wicker,et al. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse , 1987, The Journal of experimental medicine.
[19] M. Feldmann,et al. HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin , 1987, Nature.
[20] M. Dorf,et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.
[21] W. Fiers,et al. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.